LIVE

UNH

UnitedHealth Group Incorporated

UNH

NYSE·Healthcare·Medical - Healthcare Plans·Mkt cap $387.4B

$425.36

-0.28%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$234.60 - $430.20

P/E

32.12

Fwd P/E

20.32

Beta

0.65

Div Yield

2.10%

Avg Vol

7.8M

Shares Out

908.1M

Mkt Cap

$387.4B

Price action

Price chart

Up 38.7% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

5 reasons

  • Vertically integrated business model enabling end-to-end healthcare coordination and cost optimization
  • Massive scale with diversified customer base across commercial, government, and individual segments reducing revenue concentration risk
  • Advanced data analytics and technology capabilities providing actionable insights for care improvement and operational efficiency
  • Significant purchasing power in pharmaceutical procurement and provider networks enabling margin expansion
  • Established relationships with employers, providers, and government agencies creating high switching costs and customer stickiness

Bear Case

1 risk

  • Low volatility (beta 0.7).

Growth

Stable outlook

Aging population driving increased demand for Medicare and senior-focused health plans and services

Value

Fairly valued vs Managed Care & Health Insurance peers

Momentum

Hot

+53.8% over 3m

Quality

Thin

Excellent business quality

Dividend

Solid

2.10% yield

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Apr 15, 2026

Q2 26 RECAP

APR 21, 2026

Reported EPS of $7.23 vs $6.58 consensus (+9.9% surprise). Revenue of $111.7B vs $109.4B expected (+2.1%). Beat on both top and bottom lines.

EPS beat +9.9%
Rev beat +2.1%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+9.9%

Next: Apr 15, 2026

Revenue trend · last 8Q

+7%

+10%

+13%

+12%

+12%

+2%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$98.9B

$100.8B

$100.8B

$109.6B

$111.6B

$113.2B

$113.2B

$111.7B

Margins · last 8Q

Gross

22.7%

Operating

8.0%

Profit

5.6%

Wall Street consensus

17 analysts · 82% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

14

82%

Hold

2

12%

Sell

1

6%

Median Price Target

$440.00

+3.4% vs $425.36

Low $373.00
Median $440.00
High $492.00

Latest: Morgan Stanley · Jun 30, 2026

8 analysts covering

vs Industry

How UNH stacks vs Medical - Healthcare Plans

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.